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Abstract
In neurons polarized trafficking of vesicle-bound membrane proteins gives rise to the distinct molecular composition and
functional properties of axons and dendrites. Despite their central role in shaping neuronal form and function, surprisingly
little is known about the molecular processes that mediate polarized targeting of neuronal proteins. Recently, the plus-end-
directed motor Myosin Va was shown to play a critical role in targeting of transmembrane proteins to dendrites; however,
the role of myosin motors in axonal targeting is unknown. Here we show that Myosin VI, a minus-end-directed motor, plays
a vital role in the enrichment of proteins on the surface of axons. Engineering non-neuronal proteins to interact with Myosin
VI causes them to become highly concentrated at the axonal surface in dissociated rat cortical neurons. Furthermore,
disruption of either Myosin VI function or expression leads to aberrant dendritic localization of axonal proteins. Myosin VI
mediates the enrichment of proteins on the axonal surface at least in part by stimulating dendrite-specific endocytosis, a
mechanism that has been shown to underlie the localization of many axonal proteins. In addition, a version of
Channelrhodopsin 2 that was engineered to bind to Myosin VI is concentrated at the surface of the axon of cortical neurons
in mice in vivo, suggesting that it could be a useful tool for probing circuit structure and function. Together, our results
indicate that myosins help shape the polarized distributions of both axonal and dendritic proteins.
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Introduction
Following synthesis in the secretory pathway, axonal and
dendritic transmembrane proteins follow distinct transport path-
ways to the plasma membrane. After being sorted into separate
sets of vesicles at the trans-Golgi membrane [1], dendritic proteins
are transported directly to the somatodendritic domain without
entering the distal axonal domain, whereas axonal proteins enter
both axons and dendrites [2–4]. Axonal proteins that are carried
to the dendrites are unloaded onto the plasma membrane and
subsequently reloaded into vesicles that travel to the axonal
membrane [4,5]. The net effect of these processes is that axonal
transmembrane proteins are distributed roughly evenly to the
intracellular regions of both the axon and dendrites, but are
dramatically enriched on the axonal membrane.
The transport of both axonal and dendritic proteins is mediated
by kinesin motors [6–10]. However, targeting of dendritic proteins
cannot be explained by the intrinsic properties of dendritic
kinesins, such as Kif17, which cannot autonomously distinguish
between axonal and dendritic microtubules [11]. Instead, recent
work from our laboratory indicates that vesicles are targeted to
dendrites through the actions of plus-end-directed myosin motors,
which direct the vesicles away from the axon and towards the cell
body [12]. This result suggests that a minus-end-directed motor
might participate in the localization of axonal proteins. Interest-
ingly, of the 35 known classes of myosin motors, members of only
one, Myosin VI, are known to move towards the pointed (or
minus) end of actin filament [13,14]. The involvement of Myosin
VI in endocytosis further suggests that it might contribute to the
enrichment of proteins on the surface of the axon. It associates
with both clathrin-coated vesicles and proteins that mediate
endocytosis [15–17] and plays a prominent role in the endocytosis
of at least two neuronal proteins [18,19].
Here, we show that Myosin VI [20] plays a role in the
concentration of proteins at the axonal surface of neurons in
dissociated cultures. Myosin VI mediates this axonal enrichment at
least in part by enhancing dendrite-specific endocytosis. In
addition, we find evidence that is consistent with Myosin VI
promoting the direct trafficking of proteins to the axon. Thus,
myosin motors contribute to the enrichment of both axonal and
dendritic proteins at the plasma membranes of the appropriate
polar compartments. In this manner they play a role in specifying
PLoS Biology | www.plosbiology.org 1 March 2011 | Volume 9 | Issue 3 | e1001021the polarized structure of neurons, which is necessary for proper
electrical signaling.
Results
Interaction with Myosin VI Promotes Enrichment of
Proteins at the Axonal Surface
In a previous study we found that by engineering non-neuronal
proteins to interact with Myosin Va, a plus-end-directed motor, we
could target the proteins specifically to the somatodendritic
compartment. To determine whether, conversely, interaction with
the only known minus-end-directed motor, Myosin VI (Figure S1),
could direct proteins to the surface of the axon, we fused a Myosin
VI binding domain (MVIBD; Figure S2) onto the C-terminus of
the non-neuronal protein CD8 (to give CD8-MVIBD). MVIBD
consists of two known Myosin VI binding sites fused in tandem,
one from Optineurin, a protein that is associated with amyotro-
phic lateral sclerosis [21] and a second from Disabled homolog 2
(DAB2), which has been associated with prostate cancer [22].
Because each binding site interacts with a distinct region of Myosin
VI, we reasoned putting the two sites in tandem would create a
binding site with a greater affinity for Myosin VI than that of
either domain alone. Strikingly, when expressed in cortical
neurons in dissociated culture, CD8-MVIBD was highly enriched
on the surface of the axon as compared with the surface of the
soma and dendrites (Figure 1A–1C). To complement these
qualitative observations we calculated the axon to dendrite ratio
(ADR) [12], which is a relative measure of the concentration of
protein at the surface of the axon versus the dendrites. For CD8-
MVIBD the ADR of 6.661.3 (n=16) is consistent with
enrichment in the axon. This is significantly different from the
ADR of CD8 (Figure 1D and 1F; 0.860.1, n=12, p,0.0001). To
determine whether this enrichment takes place through interaction
with Myosin VI, we first blocked Myosin VI function using a
dominant negative construct consisting of its tail domain
(dominant negative Myosin VI [dnMVI]). When coexpressed
with green fluorescent protein (GFP)–dnMVI, CD8-MVIBD
localized nonspecifically, with an ADR of 0.7960.07 (n=12;
Figure 1G–1I), which is significantly different from the ADR of
CD8-MVIBD coexpressed with GFP (p,0.0001). We also tested
the effect of reducing Myosin VI levels by co-transfecting a short
interfering RNA (siRNA) against Myosin VI (Figure S3) along with
CD8-MVIBD. Under these conditions CD8-MVIBD localized
nonspecifically (ADR =0.9860.15, n=12), which is significantly
different from the ADR of CD8-MVIBD coexpressed with an
empty siRNA vector (ADR =4.060.3, n=12, p,0.0001; Figure
S4). Thus, interaction with Myosin VI can promote the
enrichment of a non-neuronal transmembrane protein at the
surface of the axon.
Myosin VI Is Necessary for Enrichment of Proteins at the
Axonal Surface
To further investigate a possible role for Myosin VI in the
concentration of proteins at the axonal surface, we examined the
effect of disrupting Myosin VI function on the distribution of
native or introduced axonal proteins. For these experiments we
chose to study the axonal proteins NgCAM, VAMP2-GFP, and
CD8-Nav, each of which has been shown to localize to the axon in
dissociated cultures [1,3,4]. Note that CD8-Nav is a fusion
between CD8 and an axonal targeting motif from the sodium
channel Nav1.2 [3]. Remarkably, while CD8-Nav, NgCAM, and
VAMP2-GFP were each substantially more concentrated on the
surface of axons than on the dendritic surface under control
conditions (ADR =6.9160.91, 5.1160.76, 6.060.44; n=15, 12,
12, respectively; Figure 2A–C), blocking Myosin VI function by
coexpression with dnMVI caused each to localize nonspecifically
(ADR =0.6160.10, 0.7960.09, 1.160.4; n=13, 13, 10, respec-
tively; p,0.0001 for each pair; Figures 2D–2G and S5). To
determine whether Myosin VI is also necessary for the
concentration of endogenous transmembrane proteins at the
axonal surface, we examined the effect of blocking Myosin VI on
localization of L1, the mammalian homolog of NgCAM and the
sodium channel Nav1.2. In cells expressing GFP, endogenous L1
(ADR =6.061.2, n=11) and Nav1.2 (ADR =3.360.3, n=15)
each were enriched at the axonal surface (Figures 3 and S5),
whereas in cells expressing GFP-dnMVI, L1 and Nav1.2 were
each present on the surfaces of both compartments at roughly
equal concentrations (ADR =1.360.2, 1.2460.1; n=11, 12;
Figures 3 and S5). The ADRs for L1 and Nav1.2 differed
significantly under the two conditions (p,0.0005 for both
comparisons).
We also tested the effect of disrupting Myosin VI with siRNA
(Figure S3) on the localization of NgCAM. NgCAM localized
nonspecifically when expressed with Myosin VI siRNA (MVI
siRNA) (ADR =1.160.1, n=12), a significant change in
distribution as compared with the distribution of NgCAM
coexpressed with an empty siRNA vector (ADR=4.5760.36;
p,0.0001; Figure 4A–4F). Moreover, we were able to rescue the
polarized distribution of NgCAM by coexpression of the MVI
siRNA with a form of Myosin VI (Myosin VI rescue [MVIr]) that
contains silent mutations that make it impervious to the MVI
siRNA (ADR =5.6760.7, n=11), a result that is significantly
different (p,0.0001) from the ADR of NgCAM when transfected
with siRNA alone (Figure 4A–4J).
In the experiments described in Figure 2 all cells that were
included exhibited polarized distributions of the axonal protein
Ankyrin G, which was used to distinguish the axon from the
dendrites (see Materials and Methods). For instance, in the
experiments in which we coexpressed NgCAM with HA-dnMVI,
Ankyrin G had an overall ADR of 661( n=13). In general,
however, the polarity of Ankyrin G was significantly reduced in
cultures that expressed HA-dnMVI (Figure 5A–5D; ADR =
Author Summary
Following synthesis in the endoplasmic reticulum (ER) and
Golgi apparatus, neuronal proteins follow divergent
trafficking pathways to the axonal and dendritic plasma
membranes. This specialized trafficking depends on motor
proteins that move along microtubules or actin in either a
‘‘plus-end’’ or ‘‘minus-end’’ direction. Although the molec-
ular details of these pathways are poorly understood,
recent work suggests that a plus-end-directed myosin
motor guides proteins preferentially to dendrites. Here we
find that Myosin VI, a minus-end-directed motor, plays a
role in the concentration of proteins at the surface of the
axon. Several studies have shown that many axonal
proteins are targeted to both compartments initially, and
are subsequently enriched on the axonal surface after they
have been specifically removed from the surface of the
dendrites by endocytosis. We show here that this dendrite-
specific endocytosis is promoted by interaction with
Myosin VI, whereas blocking Myosin VI function prevents
axonal protein from being internalized from the surface of
dendrites. Our results suggest a model where neuronal
proteins are enriched on the surface of either axons or
dendrites based on the properties of the myosin motor
with which they interact.
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n=12, p,0.0001). Expressing siRNA against Myosin VI also
reduced the polarity of Ankyrin G (Figure 5E–5I; ADR =
1.460.2, n=9) in comparison with an empty siRNA vector (ADR
=6.661.2, n=12, p,0.0002) or with siRNA and the rescue
construct MVIr (ADR =9.962, n=11, p,0.0001). Because the
elimination of Ankyrin G has been associated with the loss of
neuronal polarity [23], it is possible that axonal proteins became
mislocalized when coexpressed with dnMVI or MVI siRNA
because of a general loss of cell polarity. However, three
observations make this unlikely. First, in cells expressing dnMVI
and CD8-Nav, NgCAM, or VAMP2, the ADR of each in
Figure 1. Interaction with Myosin VI is sufficient to enrich a heterologous protein at the surface of the axon. In a cortical neuron in
dissociated culture, surface-labeled CD8 fused to MVIBD (CD8-MVIBD) (A) is highly enriched at the surface of the axon, in contrast to the nonspecific
localization of coexpressed GFP (B). (C) Merge of CD8-MVIBD (red) and GFP (green). In contrast, when CD8 (D) is coexpressed with GFP (E), it localizes
nonspecifically. (F) Merge of CD8 (red) and GFP (green) showing that the two proteins colocalize. When CD8-MVIBD (G) is coexpressed with GFP-
dnMVI (H), it localizes nonspecifically. (I) Merge of CD8-MVIBD (red) and GFP-dnMVI (green) indicates that the two proteins colocalize. (J) The average
ADR of CD8-MVIBD is greater than 6-fold higher than that of CD8 when coexpressed with GFP or of CD8-MVIBD when coexpressed with dnMVI.
*, p,0.0001; ns, p.0.5, Wilcoxon-Mann-Whitney test. Insets show staining of endogenous Ankyrin G. Arrows point to the axon; arrowheads point to
the axon initial segment. Scale bars are 10 mm.
doi:10.1371/journal.pbio.1001021.g001
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polarization of Ankyrin G in the same cells (Figure S6). Second, in
dnMVI- or MVI siRNA-expressing cells where the localization of
Ankyrin G was disrupted, dendritic proteins continued to be
localized to the dendrite (Figure S7), indicating that the diffusion
barrier was intact [24], and that overall cell polarity was not
disrupted. Finally, siRNA against Myosin VI, which disrupted
localization of Ankyrin G (Figure 5), did not disrupt the
morphological polarity of cells. Cells expressing MVI siRNA had
a density of approximately 260.3 spines per 10 mm in the
dendrites (n=13 cells), and no spines were seen on the axons
(n=13 cells; Figure S8). And in all cells expressing either dnMVI
or MVI siRNA, the axon was clearly identifiable as being the
longest process and being untapered except at the initial segment,
in dramatic contrast to the dendrites (Figure S8). Note that in
those experiments where the distribution of Ankyrin G was
unpolarized, the above morphological distinctions were used to
identify the axon and the dendrites, based on published methods
[23]. Note also that in experiments where the localization of
Ankyrin was disrupted by HA-dnMVI, the expression level of
Figure 2. Myosin VI function is necessary for enrichment of proteins at the axonal surface. In a cortical neuron expressing exogenous HA-
mCherry (A) and VAMP2-GFP (B), surface VAMP2-GFP localized specifically to the axon. (C) Merge of surface VAMP2-GFP (red) and HA-mCherry
(green). In contrast, when expressed with HA-dnMVI (D), a dominant negative version of Myosin VI, surface VAMP2-GFP (E) localized nonspecifically to
both axons and dendrites. (F) Merge of surface VAMP2-GFP (red) and HA-dnMVI (green). (G) The ADRs (see Materials and Methods) of exogenous
surface CD8-Nav, NgCAM, and VAMP2-GFP coexpressed with either GFP- or HA-tagged dnMVI (white bars), are 5- to 6-fold lower than when each is
coexpressed with either GFP or HA-mCherry (black bars). Insets show staining of endogenous Ankyrin G. Arrows point to the axon; arrowheads point
to the axon initial segment. Scale bars are 10 mm. *, p,0.0003 (Wilcoxon-Mann-Whitney test).
doi:10.1371/journal.pbio.1001021.g002
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significantly diminished compared to the control condition
(2363 a.u., n=12, p.0.07). Thus, our results suggest that
neuronal polarity is compatible with mislocalized Ankyrin G, but
do not contradict previous experiments that show that polarity
requires the presence of Ankyrin G [23].
Myosin VI Mediates Axonal Enrichment through
Dendrite-Specific Endocytosis
Several different studies have established that axonal proteins are
initially transported to dendrites as well as axons, and then
endocytosed preferentially from the dendritic surface [1,3,4]. Because
Myosin VI is known to play a role in endocytosis, we tested whether it
might mediate enrichment on the axonal membrane relative to the
surface of the dendrites at least in part through this mechanism. As a
first test of whether endocytosis is involved in the localization of
Myosin VI we compared the distributions of surface versus
intracellular CD8-MVIBD in transfected neurons. If Myosin VI
mediates dendrite-specific endocytosis, we would expect that the
intracellular distribution of CD8-MVIBD would be nonspecific, in
contrast to the distribution of surface protein, which is concentrated
to the axon. In fact this is the case: CD8-MVIBD on the cell surface
was much more strongly localized to the axon (unnormalized ADR
[uADR] =3.060.4, n=11) than was intracellular CD8-MVIBD
(uADR =0.760.06; Figure S9). This result is consistent with CD8-
MVIBD being concentrated at the axonal surface through dendrite-
specific endocytosis. Note that because we labeled both surface and
intracellular protein in the same cells, we were not able to label a
nonspecifically localized protein and thus we used an unnormalized
ADR (see Materials and Methods).
To more directly investigate whether Myosin VI contributes to the
concentration of proteins at the axonal surface through dendrite-
specific endocytosis, we tested whether interaction with Myosin VI
affects the rate of internalization of surface protein. For these
experiments, we measured the relative amount of CD8-MVIBD as
compared with CD8 that is endocytosed from the surface of the axon
or the dendrites during a 30-min time period. In live cortical neurons,
exogenous CD8-MVIBD or CD8 was labeled with an antibody
directed against an external epitope, and endocytosis of surface
proteins was allowed to proceed for 30 min at 37uC. The neurons
were then washed in acidic medium (pH=2) in order to eliminate
antibody that was bound to protein on the surface. Finally, the cells
were fixed, and the internalized protein was stained under
permeabilized conditions with a secondary antibody. To determine
the effect of Myosin VI on endocytosis, we compared the amount of
internalized CD8 versus CD8-MVIBD in each compartment.
Overall, 2.5 times more CD8-MVIBD was internalized (109620
a.u., n=12) as compared with CD8 alone (3968a . u . ,n=14,
p,0.0003). Moreover, incubating the cells with Dynasore, a blocker
of endocytosis, reduced the levels of endocytosed CD8-MVIBD to an
amount similar to those obtained when CD8 was expressed alone
(3463a . u . ,n=12, p,0.0001; Figures 6A–6G and S10) [25]. To
determine whether interaction with Myosin VI produced an increase
in dendritic as compared with axonal endocytosis, we compared the
relative amount of protein that had internalized in the dendrites
versus the axon. The ADR of internalized CD8-MVIBD under
control conditions (0.4160.11) was approximately 2.5-fold lower
(more dendritic) than the ADR of CD8 (Figure 6G; 0.9360.21) or of
CD8-MVIBD in the presence of Dynasore (1.160.3), a significant
difference (p,0.001) that indicates that interaction with Myosin VI
causes dendrite-specific endocytosis. Note that this exposure to low
pH did not appear to affect the localization of endogenous Ankyrin G
or of Nav1.2, suggesting that it did not harm the cell (Figure S10).
Since it appears from the above experiments that interaction
with Myosin VI promotes dendrite-specific endocytosis, we asked
whether Myosin VI is necessary for endocytosis of exogenously
expressed VAMP2, a protein that is enriched at the surface of the
axon through a Myosin VI-dependent process (Figure 2). In
experiments similar to those described in the previous paragraph,
less VAMP2 was internalized when coexpressed with GFP-dnMVI
(761 a. u., n=11; Figure 7A–7E) than when it was coexpressed
with GFP (4665 a.u., n=11), a significant difference (p,0.0001).
Furthermore, the internalized protein was concentrated in the
dendrites in the control condition (ADR =0.4360.05), but was
slightly concentrated in the axon when Myosin VI activity was
blocked (Figure 7; ADR =1.660.3), a significant difference
(p,0.003). This result indicates that Myosin VI is necessary for
dendrite-specific endocytosis. Finally, we wanted to determine
whether endocytosis is required for the concentration of proteins at
the axonal surface that is mediated by Myosin VI. To this end, we
tested the effect of the presence of the endocytosis blocker
Dynasore on the surface distribution of CD8-MVIBD. When
expressed in the presence of Dynasore, surface CD8-MVIBD was
enriched on the surface of the axon (Figure 8A–8C; ADR =
2.160.2, n=13), but to a much lesser extent than CD8-MVIBD
under control conditions (Figure 8D–8G; ADR =560.3, n=14,
p,0.0001). Together, our results suggest that interaction with
Myosin VI increases the rate of endocytosis in the dendrites
Figure 3. Blocking Myosin VI function blocks the concentration
of endogenous Nav1.2 at the axon. In a cortical neuron transfected
with GFP-dnMVI (A), endogenous Nav1.2 (B) localizes in both axons and
dendrites in a nonspecific manner. In contrast, in a neuron expressing
GFP (C), endogenous Nav1.2 (D) is localized specifically to the axon. (E)
The ADRs of endogenous L1 and Nav1.2 were significantly higher when
coexpressed with GFP (black bars) than when coexpressed with GFP
dnMVI (white bars). *, p,0.0005, Wilcoxon-Mann-Whitney test. Arrows
point to the axon; arrowheads point to the axon initial segment. Scale
bars are 10 mm.
doi:10.1371/journal.pbio.1001021.g003
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protein on the axonal surface.
Myosin VI Promotes Direct Trafficking to the Axon
In the previous experiments we noted that while blocking
endocytosis reduced the degree to which the distribution of CD8-
MVIBD was polarized, the protein still displayed enrichment in the
axon (ADR =2.160.2, from above). Indeed, the ADR of surface
CD8-MVIBD in the presence of Dynasore was still significantly
larger than that of surface CD8 (ADR =0.8060.13, n=12,
p,0.001). Thus, eliminating endocytosis does not completely
eliminate the relative enrichment of protein on the surface of the
Figure 4. Knockdown of Myosin VI with siRNA blocks axonal enrichment of NgCAM. In a cortical neuron transfected with siRNA against
Myosin VI (MVI siRNA), surface exogenous NgCAM (A) localized both to axons and to dendrites, with an expression pattern that overlaps that of GFP
(B). (C) Merge of surface NgCAM (red) and GFP (green) in a cell coexpressing MVI siRNA. In contrast, NgCAM (D) was enriched on the surface of the
axon when expressed with GFP (E). (F) Merge of surface NgCAM (red) and GFP (green). When expressed with both siRNA against Myosin VI and a
version of Myosin VI that is impervious to siRNA (MVIr), surface NgCAM (G) localized specifically to the axon, in contrast to the nonspecific localization
of GFP (H). (I) Merge of surface NgCAM (red) and GFP (green) in a cell cotransfected with MVI siRNA and MVIr. (J) When coexpressed with either GFP
alone or with MVI siRNA and MVIr, NgCAM localized to the axon with an ADR 4- to 5-fold higher than when NgCAM was coexpressed with MVI siRNA
alone. Arrows point to the axon; arrowheads point to the axon initial segment. Scale bars are 10 mm. *, p,0.0001 (Wilcoxon-Mann-Whitney test).
doi:10.1371/journal.pbio.1001021.g004
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in directtrafficking of proteins to the axon. To explore thisquestion,
we looked specifically at whether interactionwith Myosin VI caused
proteins to travel preferentially to the axonduring the initialstage of
trafficking,beforetheproteinisdepositedonthe plasmamembrane.
Accordingly, we generated cleavable tags on CD8 and CD8-
MVIBD by attaching GFP to the extracellular N-terminal domains
of each protein by means of a linker encoding a Thrombin cleavage
site (tcs) (to give CD8-tcs-GFP and CD8-MVIBD-tcs-GFP).
Following transfection of cortical neurons with these constructs,
Thrombin was added to the medium so that the GFP tags were
removed immediately upon arrival of the proteins on the cell
surface. We confirmed that a substantial pool of protein,
representing protein that had not yet reached the surface of the
cell, could be visualized following fixation and permeabilization,
while protein on the cell surface, visualized with surface staining
without permeabilization, was nearly entirely cleaved (Figure S11).
Thus, this method can be used to look at the initial stage of
trafficking prior to delivery at the cell surface.
Using this method we found internal CD8-MVIBD was over
3.5-fold more concentrated in the axon (uADR =0.6260.07,
n=12) than was comparable CD8 (uADR =0.1760.02, n=13), a
difference that is statistically significant (p,0.0001). Note that
because we internally controlled for the success of the thrombin
cleavage in every experiment, we could not also visualize the
distribution of non-localized proteins and therefore calculated an
unnormalized ADR (see Materials and Methods). Interestingly, in
the case of both CD8 and CD8-MVIBD, the ADR was less than 1,
indicating that protein is more concentrated in the somatoden-
dritic region than in the axon. However, these figures must be
interpreted with caution as the ER and Golgi are almost entirely
located within the soma and dendrites (Figure S11; [26,27]). Thus,
the staining in the dendrites (Figure 9A and 9B) includes protein at
the early stages of the secretory pathway prior to release from the
Golgi as well as post-Golgi protein, whereas protein stained in the
axon includes only post-Golgi protein. For this reason, the relative
degree of axonal localization due to direct trafficking can be better
appreciated by comparing the relative amounts of CD8 and CD8-
MVIBD in the axon following exposure to Thrombin (Figure 9C).
Interaction with Myosin VI causes enrichment of greater than 3-
fold in the axon (axonal CD8-MVIBD =2863 a.u., CD8=961
a.u.), a significant difference (p,0.0001), whereas the expression
level of protein in the dendrites is comparable (dendritic CD8-
MVIBD =94610, CD8=81611, p.0.3; Figure S11) with or
without interaction with Myosin VI.
To further test the hypothesis that Myosin VI contributes to
direct axonal trafficking, we examined the effect of disrupting
Myosin VI on a mutant of NgCAM (NgCAMY33A) that
previously had been shown to be enriched on the surface of the
axon independent of endocytosis [5]. NgCAMY33A localized
specifically to axons when expressed in dissociated cortical neurons
in combination with GFP (ADR =4.960.4, n=13) but was
nonspecifically localized when expressed with GFP-dnMVI
(Figure 10A–10G; ADR =0.960.3, n=13), results that are
significantly different (p,0.0001). Thus, Myosin VI is necessary for
the localization of an NgCAM mutant that traffics directly to the
axon. Together, the experiments in Figures 9 and 10 provide
evidence that Myosin VI contributes to the direct trafficking of
transmembrane proteins to the axon.
Interaction with Myosin VI Enriches Channelrhodopsin-2
on the Axonal Surface of Cortical Neurons In Vivo
In a previous study we showed that causing Channelrhodopsin-2
(ChR2), an ion channel that produces cationic currents in response
to blue light [28], to interact with Myosin Va was sufficient to target
it to the somatodendritic region of neurons in vivo, creating a new
tool that can be used for circuit mapping [12]. Given that MVIBD
can robustly enrich CD8-MVIBD at the surface of the axon
(Figure 1), we asked whether it might similarly localize ChR2 in
vivo. Using electrophysiological methods we compared the
subcellular localizations of a fusion of ChR2, MVIBD, and GFP
(ChR2-MVIBD-GFP) versus ChR2 (ChR2-GFP) in layer 2/3
pyramidal neurons of the somatosensory cortex. Experiments were
performed on cortical slices cut from postnatal day 15–23 mice that
were transfected at embryonic day 16 via in utero electroporation
(Figure S12). By recording from layer 2/3 neurons intracellularly
(and in the presence of CPP (5 mM) and NBQX (10 mM)) while
stimulating with blue light in a raster pattern covering five cortical
layers (Figure 11A), we mapped the locations where activation
produced actionpotentials (APs) indicating the presence ofa process
of the recorded cell where ChR2 was present on the plasma
membrane. Moreover, by examining the shape of the AP it was
possible to determine whether the process that was stimulated was
axonal or somatodendritic (see Materials and Methods; Figures 11B
and S13) [12]. Note that all APs with characteristics indicating they
wereevoked at dendritic locations (n=175) weremappedto layers 2
and 3 and not to layers 4 and 5, which contain only axons of layer
2/3 cells, an indication that this classification method is accurate.
To gauge the relative localization of ChR2 constructs we
compared the number of locations where APs were produced by
stimulation of axons to the number produced by stimulation of
dendrites at several different laser powers for each cell. Strikingly,
two of six cells expressing ChR2-MVIBD-GFP showed excitation
only in the axon (in comparison with zero of eight cells expressing
ChR2-GFP; Figure 11C). In order to quantify relative localization
of ChR2 versus ChR2-MVIBD, we calculated the ratio of the
number of dendritic versus axonal excitation sites to give the
electrophysiological dendrite to axon ratio (eDAR). Comparison of
eDAR versus power for individual cells expressing ChR2-GFP
versus ChR2-MVIBD-GFP (Figure 11D) shows that ChR2-
MVIBD-GFP is present at a higher concentration in the axon
than ChR2-GFP at virtually all laser powers tested. We assessed
eDAR for each cell by averaging overall laser powers and found
that ChR2-GFP localized with an eDAR over five times greater
than that of ChR2-MVIBD-GFP (eDAR =0.1360.03,
0.02360.009; n=8, 6, respectively), a result that is statistically
significant (p,0.001). Note that because the axons of layer 2/3
pyramidal neurons tend to be considerably larger than the
dendrites [29], eDARs of ChR2-GFP tend to be smaller than 1
(Figure 11C). The eDAR results are consistent with maps of the
expression patterns of ChR2-GFP and ChR2-MVIBD-GFP
showing the presence of ChR2-MVIBD-GFP protein to a lesser
extent in the dendrites and to an equal or greater extent in the
axons when compared to ChR2-GFP (Figure 11C). Thus, fusion
with the MVIBD is sufficient to cause ChR2 to be enriched on the
surface of axons in vivo. Furthermore, ChR2-MVIBD allows
neurons to be stimulated preferentially in the axon, a tool that will
be useful for probing both the anatomical and functional
properties of neuronal circuits.
Discussion
The data in this study indicate that Myosin VI plays a role in
the enrichment of transmembrane proteins at the axonal surface.
Myosin VI facilitates the relative enrichment of proteins at the
surface of the axon by increasing the rate of endocytosis within the
somatodendritic compartment relative to the axonal compart-
ment. Overall, our results are consistent with a model whereby
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and the dendrites following release from the Golgi apparatus
(Figure S14). Following arrival of protein at the somatodendritic
plasma membrane, it is endocytosed through the actions of
Myosin VI. This participation of Myosin VI in dendritic
endocytosis of axonal proteins is consistent with numerous reports
documenting its role in endocytosis in epithelial cells and neurons
as well as in nonpolarized cells [15,18,30,31]. It remains to be
determined the exact mechanism whereby specificity of Myosin VI
action is achieved. It is possible that Myosin VI interacts either
directly or indirectly with axonal proteins, or, alternatively, it is
possible that Myosin VI interacts with the endocytic machinery
associated with vesicles carrying these proteins [32]. In the future it
will be important to fully explore this question.
With the results of this study, there is now evidence that actin
and myosin play pivotal roles in the concentration of proteins on
the surface of either the axon or the dendrites; however, the role of
microtubule-based mechanisms in these processes is less clear. A
number of observations indicate that kinesin motors might be
involved in steering vesicles to polarized compartments. For
instance, the motor domain of Kif17, which transports dendritic
proteins [6,7], carries vesicles into the axon less efficiently than
Kif5, which transports both axonal and dendritic proteins [33].
Tailless Kif5 targets to axons in a manner that is dependent on
microtubule dynamics [11], and blocking Kif5 function with
dominant negative constructs disrupts neuronal polarity [33].
Additionally, tyrosination, a phenomenon that occurs in dendrites,
but not axons, causes Kif5 to bind at lower affinity to dendritic
microtubules in comparison to those present in the axon [34,35].
Finally, Kif5 prefers to bind to stable microtubules, which
predominate in the axon, whereas other kinesins can also interact
with unstable microtubules, which predominate in dendrites [36].
Although these experiments suggest that Kif5 has a bias towards
axonal transport, it is also capable of carrying proteins such as
GluR2 to the dendrites [8]. The work in this paper and our
previous work would suggest that APP, which is also carried by
Kif5 [37], and GluR2 localize differently because APP is carried in
vesicles that associate with active Myosin VI, whereas vesicles
carrying GluR2 likely are influenced by the actions of a plus-end-
directed Myosin, such as Myosin Va [12]. Nonetheless, our
experiments do not rule out an active role for kinesins in polarized
targeting. For instance, it has been shown that Kif5 likely plays a
role in the initial establishment of neuronal polarity during early
development in vitro when it carries C-Jun N-Terminal Kinase to
the nascent axon [38,39]. Thus, under certain circumstances,
kinesin motors are capable of targeting specifically to one or the
other polarized compartment. However, the results in this paper
and our previous study [12] would indicate that in many cases
contributions by myosin motors are required for polarized
trafficking.
In addition to kinesins, the dynein complex has also been
suggested to participate in the polarized targeting of dendritic
proteins, since causing organelles to link to dynein results in their
transport specifically to dendrites [40]. While this effect is
remarkably robust, it is not surprising given the fact that only
dendrites contain microtubules that are oriented in a direction that
permits movement of dynein away from the cell body and into the
process [41]. Although blocking dynein with Dynamitin blocked
dendritic targeting of GluR2, this disruption was not distinguished
from the disruption of neuronal polarity in general. In contrast,
blocking the function of Myosin Va or Myosin VI specifically
disrupts the polarized distribution of subsets of proteins without
destroying the overall polarity of the cell ([12]; Figures 2 and S6–
S8). Furthermore, the assertion that dendritic proteins are
specifically transported by dynein motors and not by kinesins
would appear to contradict numerous studies [6–8,42]. A model
where dynein plays a crucial role in the maintenance of the
cytoskeletal structure that is essential for neuronal polarity, while
myosin motors in combination with kinesins mediate trafficking, is
consistent with both our work and that of others.
Recent experiments support the existence of a vesicle filter
dependent on actin within the axon initial segment. For instance,
when large molecules are injected into the cell body of dissociated
hippocampal neurons in culture, they are excluded from the axon
Figure 5. Myosin VI function is necessary for axonal enrich-
ment of Ankyrin G. Endogenous Ankyrin G (A) localizes very
specifically to the axon initial segment in neurons expressing GFP (B).
In contrast, Ankyrin G (C) localizes in a relatively nonspecific manner in
neurons expressing GFP-dnMVI (D). Similarly, endogenous Ankyrin G (E)
localizes nonspecifically when coexpressed with MVI siRNA and GFP (F).
In contrast, endogenous Ankyrin G (G) when coexpressed with MVIr and
GFP (H) localizes specifically to the axon initial segment. (I) ADRs
indicate that disrupting Myosin VI function or expression causes
Ankyrin G to localize nonspecifically. *, p,0.0002. Arrows point to the
axon; arrowheads point to the axon initial segment. Scale bars are
10 mm.
doi:10.1371/journal.pbio.1001021.g005
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which promotes actin depolymerization [33]. Latrunculin B,
which also promotes actin depolymerization, disrupts the locali-
zation of numerous polarized proteins including NgCAM [24].
Moreover, electron microscopy studies show the presence of actin
filaments, albeit of indeterminate orientation, below the axolemma
[43]. Our previous results suggested that this filter might play a
role either in preventing entry of dendritic proteins into the axon
[12,44] or in promoting their entry into dendrites. In this study we
found that a protein bound to Myosin VI (CD8-MVIBD) is
localized intracellularly to both the axon and the dendrites (Figure
S9), which would imply that there is nothing preventing it from
entering the dendrites and thus that no vesicle filter exists in the
proximal dendrites. In addition, a vesicle filter present in the axon
initial segment that prevents proteins associated with Myosin Va
from entering the axon would have the opposite effect on proteins
associated with Myosin VI. Thus, Myosin VI might interact with
actin filaments to guide vesicles containing axonal proteins and
carried by kinesins towards the axon (Figure S14).
The presence of a vesicle filter in only one compartment could
explain why axonal and dendritic proteins are trafficked by distinct
mechanisms in mammalian neurons: (1) Axonal proteins associ-
ated with Myosin VI initially enter both compartments, but are
concentrated in the axon in part through Myosin VI-dependent
endocytosis from the dendritic plasma membrane. (2) Vesicles
carrying dendritic proteins, which associate with Myosin Va, are
prevented from entering the distal axon by its vesicle filter, which
causes the vesicles to be trafficked directly to the dendrites. In
invertebrates, however, it appears that localization of both axonal
and dendritic proteins depends on endocytosis from the plasma
membrane of the opposite compartment. Thus, in Caenorhabditis
elegans, several dendritic receptors including the acetylcholine
receptor and a glutamate receptor are localized to dendritic
membranes through axon-specific endocytosis, while Synaptogyrin
is localized to the axon through endocytosis from the somatoden-
dritic membrane [45,46]. It seems likely that in the relatively
compact neurons of invertebrates, endocytic mechanisms alone
are sufficient to localize transmembrane proteins efficiently to the
membrane of either the axon or the dendrite. Thus, it is tempting
to speculate that the advent in vertebrates of neurons with very
long, thin axons dramatically increased the cost of localization
strategies dependent on endocytosis. This development might have
exerted sufficient selective pressure to facilitate the formation of a
cytoskeletal structure, the vesicle filter, which prevents vesicles
containing dendritic proteins from entering axons and promotes
the entry of vesicles containing axonal proteins.
Materials and Methods
cDNA Constructs
VAMP2-YFP was constructed by inserting the sequence
encoding amino acids 1–116 59 to the gene encoding YFP.
CD8-Nav was constructed by inserting the DNA sequence
encoding amino acids 1839–1870 of NaV1.2 39 to the sequence
encoding amino acids 1–227 of CD8. GFP-dnMVI was construct-
ed by inserting the DNA encoding the last 452 amino acids of rat
Myosin VI 39 to the GFP gene. HA-dnMVI was assembled by
inserting the DNA encoding two hemagglutinin tags 59 to the
DNA encoding the final 452 amino acids of rat Myosin VI. The
sequence for MVI siRNA is 59-aacttcgaagtactggagccagcttcatc-39
(OriGene). In Myosin VI, amino acids R660 and S661 are
encoded by 59-cgaagt-39; in MVIr, R660 and S661 are encoded by
59-cgctct-39. CD8-Optineurin was constructed by placing the
DNA encoding amino acids 1–227 of CD8 59 to the DNA
encoding Optineurin amino acids 420–526. CD8-DAB2 was
constructed by placing the DNA encoding amino acids 1–227 of
CD8 59 to the DNA encoding DAB2 amino acids 649–719. CD8-
MVIBD contains the DNA encoding amino acids 1–227 of CD8
59 to the DNA encoding Optineurin amino acids 420–526 and the
DNA encoding DAB2 amino acids 649–719. CD8-MVIBD-tcs-
GFP and CD8-tcs-GFP were constructed by inserting the DNA
encoding the GFP gene and the amino acids LVPRGS 59 to the
DNA encoding CD8-MVIBD and CD8, respectively. GFP-
MVIBD was constructed by replacing the DNA encoding CD8
from CD8-MVIBD with the DNA encoding GFP. NgCAM (a
generous gift from Gary Banker) was altered by placing a stop
codon 59 to the YFP gene. NgCAMY33A was constructed by
mutagenizing the DNA encoding amino acid Y1186 to an alanine
codon. GFP-GluR1and TfR-HA were previously described by
Lewis et al [12]. Streptavidin (SA)–KDEL was made from GFP-
KDEL [47], a gift from Katsuhiko Mikoshiba by substituting SA
for GFP.
Dissociated Cultures
Briefly, we removed the brains from day 18 embryos and
dissected the cortices in Hanks balanced salt solution (Invitrogen)
supplemented with 1 mM HEPES (Invitrogen). Cortices were
dissociated in HBSS plus HEPES with 0.25% trypsin for 15 min
and then washed three times for 5 min each with HBSS plus
HEPES. The dissociated neurons were then plated on coverslips
(22 mm622 mm, Fisher) at a density of 1610
4 or 5610
4 cells per
well in neurobasal medium (Invitrogen) supplemented with 10 ml/
l Glutamax (Invitrogen), 1 mg/ml gentamicin (Invitrogen), 20 ml/l
B-27 supplement (Invitrogen), and 50 ml/l fetal bovine serum
(Invitrogen). After 4 h the medium was replaced with serum-free
neurobasal medium. All cells were transfected using CalPhos
(Clontech) at 12–18 d in vitro using the manufacturer’s suggested
protocol. In order to determine the effect of dnMVI on exogenous
proteins, it was expressed for 2 d, whereas its effect on endogenous
proteins was determined after 7 d of expression. siRNA constructs
were expressed for 14 d. Experimental protocols were conducted
according to the United States National Institutes of Health
guidelines for animal research and were approved by the
Institutional Animal Care and Use Committee at the University
of Southern California.
Immunocytochemistry
The cells were fixed with 4% paraformaldehyde for 5 min and
washed with PBS. This was followed by blocking with 1% bovine
serum albumin, 5% normal goat serum, and 0.1% Triton X-100
in PBS. After blocking, primary antibody was diluted in blocking
solution and added for 30–120 min. Secondary antibody was
diluted in blocking solution and added for 30 min in the dark.
Primary antibody concentrations were as follows: chicken anti-
GFP (Aves), 1:1,000; rabbit anti-GFP (BD Biosciences), 1:1,000;
mouse anti-HA (Covance), 1:500; rabbit anti-Ankyrin G (Santa
Cruz), 1:1,000; mouse anti-Ankyrin G (Neuromab), 1:500; mouse
anti-CD8 (Dako), 1:100; rabbit anti-Myosin VI (Proteus), 1:100;
rabbit anti-bIV Spectrin (a generous gift from Matthew
Rasband), 1:1,000; mouse anti-Nav1.2 (Neuromab), 1:50; and
mouse anti-Beta Tubulin (Sigma), 1:1,000. The mouse anti-
NgCAM (8D9, 1:100), developed by Vance Lemmon, and the
mouse anti-L1 (ASCS4, 1:50), developed by Paul H. Patterson,
were obtained from the Developmental Studies Hybridoma Bank
initiated under the auspices of the National Institute of Child
Health and Human Development and maintained by the
Department of Biological Sciences, University of Iowa. Second-
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PLoS Biology | www.plosbiology.org 9 March 2011 | Volume 9 | Issue 3 | e1001021Figure 6. Interaction with Myosin VI promotes dendrite-specific endocytosis. (A) Internalized exogenous CD8-MVIBD that was labeled with
anti-CD8 antibody and incubated for 30 min at 37uC in a cortical neuron in dissociated culture. Internalized protein was concentrated in the
dendrites. (B) Internalized exogenous CD8 labeled under conditions identical to those in (A). (C) Internalized exogenous CD8-MVIBD labeled under
conditions identical to those in (A), except with Dynasore, a blocker of endocytosis, included in the bath. (D–F) GFP labeling of the neurons in (A–C),
respectively. Insets show staining of endogenous Ankyrin G. (G) Significantly more CD8-MVIBD than CD8 was internalized from cortical neurons in
culture in a 30-min time frame. Internalization of CD8-MVIBD could be blocked by the presence of Dynasore in the medium. ADRs of CD8 versus CD8-
MVIBD, which are significantly different, indicate that interaction with Myosin VI causes endocytosis to occur preferentially in the dendrites. ADRs of
CD8-MVIBD in the presence versus absence of Dynasore were also significantly different. *, p,0.001; **, p,0.0003; Wilcoxon-Mann-Whitney test.
Insets show staining of endogenous Ankyrin G. Arrows point to the axon; arrowheads point to the axon initial segment. Scale bars are 10 mm.
doi:10.1371/journal.pbio.1001021.g006
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fluorophores (Invitrogen).
Surface Immunocytochemistry
Fresh neurobasal medium without serum and with primary
antibody added was placed on the cells for 5–10 min. The cells
were then treated as stated in the immunocytochemistry section.
For the CD8-MVIBD intracellular versus surface immunocyto-
chemistry, the coverslips were stained live for 5 min, then fixed
and washed with PBS. Directly after the washes, Alexa 594 was
added in block without Triton X-100 for 30 min. The cells were
then blocked with Triton X-100 for 30 min, and stained for
intracellular protein as stated in the immunocytochemistry section
above.
siRNA Experiments
Neurons were transfected as stated above with MVI siRNA,
empty siRNA vectors, or MVI siRNA + MVIr. After 16 h, the
cells were rinsed twice with NaCl HEPES buffer (140 mM NaCl,
5 mM KCl, 1 mM MgCl2, 24 mM D-glucose, 10 mM HEPES,
and 1 mM CaCl2 [pH 7.4]) and placed into conditioned
neurobasal medium for 13 d. On the 14th day, the cells were
fixed and stained as stated in the immunocytochemistry section
above.
Internalized Anti-CD8 Experiments
Neurons were transfected as above with CD8-MVIBD or CD8.
Forty minutes prior to additionof antibodyeither DMSO or 15 mM
Dynasore (CalBioChem) was added to each well. After 48 h of
expression, mouse anti-CD8 was added to the medium for 30 min
at 37uC. Following antibody feeding, the cells were washed with
pH 2 medium for 2 min. The cells were then stained as explained
above. Final DMSO concentration in the medium was 0.1%.
Endocytosis Block by dnMVI
Neurons were transfected as above with VAMP2-YFP and
either GFP or GFP-dnMVI. After 48 h of expression, chicken
anti-GFP was added to the medium for 30 min at 37uC. Following
antibody feeding, the cells were washed with pH 2 medium for
2 min. The cells were then fixed and stained for intracellular
protein with rabbit anti-GFP and anti-Ankyrin G.
Thrombin Cleavage Experiments
Neurons were transfected as stated above with CD8-MVIBD-
tcs-GFP or CD8-tcs-GFP. After 6 h, the cells were placed in
conditioned medium equilibrated for at least 2 h to 10% CO2 at
37uC for 15 min in 5% CO2 at 37uC to remove excess CalPhos
crystals. The neurons were then placed in conditioned medium
containing 2 units/ml Thrombin (Sigma) for 16 h. Lastly, the
neurons were surface stained, as previously stated, with chicken
anti-GFP, then fixed and stained for intracellular protein with
rabbit anti-GFP and anti-Ankyrin G.
Biotinylated Thrombin
Thrombin (Sigma) was biotinylated with a biotinylation kit from
Pierce. After transfection with DNA encoding GFP, biotinylated
Thrombin was added to the cells at 2 units/ml Thrombin for 16 h.
The cells were washed with 16PBS, then fixed and stained with
chicken anti-GFP and biotin-rhodamine (Invitrogen).
Dynasore Experiments
Neurons were transfected as stated above with CD8-MVIBD-
tcs-GFP and GFP. After 6 h, the cells were placed in conditioned
medium equilibrated for at least 2 h to 10% CO2 at 37uC for
15 min in 5% CO2 at 37uC to remove excess CalPhos crystals.
The neurons were then placed in conditioned medium containing
either DMSO or 15 mM Dynasore (CalBioChem). After 24 h, the
neurons were surface stained, as previously stated, with chicken
anti-GFP, then fixed and stained for total protein with rabbit anti-
GFP and anti-Ankyrin G. Final DMSO concentration in the
medium was 0.1%.
Myosin VI and GFP-MVIBD Co-Immunoprecipitation
COS cells were transfected via Effectene (Qiagen) with Myosin
VI HA and either GFP-MVIBD or GFP alone. After 48 h, lysate
was prepared in lysis buffer (150 mM NaCl, 1 mM EDTA,
10 mM Tris [pH 8.0], 1% NP40, 0.12 mg/ml PMSF, 2 mg/ml
Leupeptin, 1 mg/ml Aprotinin, 10 mM NaF, and 1 mg/ml
Pepstatin [all from Sigma]). The lysate was pre-cleared with
agarose beads for 2 h at 4uC, and then 50 ml of goat anti-HA
beads (Abcam) were added to 500 mg of lysate O/N at 4uC. The
following day, the beads were washed five times with the lysis
buffer above except the detergent was reduced to 0.1% NP40. The
beads were collected in 56 SDS sample buffer and boiled for
Figure 7. Interaction with Myosin VI is necessary for dendrite-
specific endocytosis. Internalized exogenous VAMP2 (A) is localized
primarily to dendrites in a cortical neuron coexpressing GFP (B). In
contrast, much less VAMP2 (C) was internalized in cells coexpressing
GFP-dnMVI (D). (E) Significantly more VAMP2 was internalized when it
was coexpressed with GFP than when it was coexpressed with GFP-
dnMVI. Furthermore, ADRs show that VAMP2 was internalized
preferentially from the surface of the dendrites when coexpressed with
GFP, but was internalized roughly equally from surfaces of the dendrites
and from the axon when coexpressed with GFP-dnMVI. *, p,0.003; **,
p,0.0001; Wilcoxon-Mann-Whitney test. Arrows point to the axon;
arrowheads point to the axon initial segment. Scale bars are 10 mm.
doi:10.1371/journal.pbio.1001021.g007
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transferred to nitrocellulose blot paper (Pall). The blots were then
probed with either mouse anti-HA (Covance), 1:3,000, or rabbit
anti-GFP (BD Biosciences), 1:2,000. Secondary antibodies used
were goat anti-mouse HRP (Invitrogen), 1:10,000, or goat anti-
rabbit HRP (Invitrogen), 1:5,000. The blots were developed with
Western Lighting ECL-Plus (PerkinElmer) and transferred to film
(Kodak).
Myosin VI siRNA Biochemistry
COS cells were transfected via Effectene (Qiagen) with Myosin
VI or MVIr and either empty siRNA or MVI siRNA. After 4 d,
lysate was prepared as above. Finally, the samples were then run
on SDS-PAGE gels and transferred to nitrocellulose blot paper
(Pall). The blots were then probed with either mouse anti-HA
(Covance), 1:3,000, or mouse anti-b tubulin (Sigma), 1:1,000.
Secondary antibody used was goat anti-mouse HRP (Invitrogen),
1:10,000. The blots were developed with Western Lighting ECL-
Plus (PerkinElmer) and transferred to film (Kodak).
Image Capture and Analysis
All imaging was done on a Bio-Rad MRC-1024 confocal
microscope. Each cell was imaged as a single optical section. Each
image was taken with a 640 objective and at 61 zoom, unless
Figure 8. Axonal enrichment mediated by Myosin VI involves endocytosis. In a cortical neuron in dissociated culture in the presence of
Dynasore, CD8-MVIBD (A) is expressed on the surface of both the axonal and somatodendritic compartments, although there is a preference for the
axonal surface. (B) GFP coexpressed in the same cell as in (A). (C) Merge of CD8-MVIBD (red) and GFP (green). In contrast, CD8-MVIBD (D) is highly
enriched on the surface of the axon when coexpressed with GFP (E) under control conditions. (F) Merge of CD8-MVIBD (red) and GFP (green). (G) The
ADR of CD8-MVIBD is significantly reduced when it is expressed in the presence of Dynasore as compared with a control condition. *, p,0.0001.
Insets show staining of endogenous Ankyrin G. Arrows point to the axon; arrowheads point to the axon initial segment. Scale bars are 10 mm.
doi:10.1371/journal.pbio.1001021.g008
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contained any saturated pixels in the axon or dendrites. Cells that
had clearly definable axons and overall healthy morphology and
were not obscured by neighboring cells were chosen on the basis of
GFP or HA-mCherry staining. In general cells chosen for analysis
had enriched Ankyrin G in the axon initial segment that allowed for
identificationoftheaxon;howevertherewerethreeexceptions:(1)in
the experiments where dendritic proteins were coexpressed with
tagged dnMVI, where we purposely chose cells independent of
Ankyrin G staining (Figure S7) to insure that we did not bias the
results towards minimal effects; (2) in the experiments where
NgCAM or CD8-MVIBD was coexpressed with MVI siRNA
(Figures 4 and S4), because these experiments required a long
incubation time, after which Ankyrin G localization was eliminated;
and(3)intheexperimentswheretheeffectofdnMVIonendogenous
proteinswasassessed(Figures3and S5).Theseexperimentsrequired
a long incubation timefor endogenousproteinsto turnover. In these
cases we identified the axon as (1) the longest process, (2) lacking
dendritic spines, and (3) untapered except for the proximal region.
Note that similar criteria were used to identify the axon previously
[23]. To test whether these criteria were sufficient to identify axons,
104 neurons were stained with a nonspecifically localized protein
such as GFP or HA-mCherry and then counterstained with Ankyrin
G. In each case, the axon was identified from the nonspecifically
stained images. After comparison with the Ankyrin G staining, in
each case it was confirmed that all 104 axons were successfully
identified using the morphological criteria.
To quantify the degree of polarization in the distribution of a
particular protein (P1) we calculated the ADR. We calculated two
different forms of ADR, normalized (ADR) and unnormalized
(uADR). In both cases, we calculated the mean amount of
fluorescence per pixel in the entirety of the dendrites and in the
axon distal to the initial segment (with background subtracted
from both). We then calculated the ratio of these values to give the
uADR, which for most nonspecifically localized proteins was
somewhere between 0.2 and 0.3.
uADR~
FP1,axon
FP1,dendrite
ð1Þ
where FP1,axon is the average fluorescence intensity per pixel of
protein P1 in the axon.
For normalized ADR, we then divided by the ratio of the mean
fluorescence per pixel in the axon to the mean fluorescence per
pixel in the dendrites of a nonspecifically localized protein such as
GFP.
ADR~
uADR
FmFP,axon
FmFP,dendrite
 ! ð2Þ
where FmFP,axon
FmFP,dendrite
is the mean fluorescence intensity per pixel
associated with GFP or HA-mCherry in the axon or dendrite.
The advantage of calculating the normalized ADR is that it is
simpletointerpret,asADR =1indicatesa proteinisnonspecifically
localized, ADR ,1 indicates a dendritically localized protein, and
ADR .1 indicates an axonally localized protein.
All measurements were done using ImageJ (US National
Institutes of Health). All values of ADR were expressed 6 the
standard error of the mean. Comparisons of ADRs were made with
the Wilcoxon-Mann-Whitney test, which can test the significance of
nonparametric data. All analyses were performed blinded.
In Utero Electroporation
Experimental protocols were conducted according to the US
National Institutes of Health guidelines for animal research and
were approved by the Institutional Animal Care and Use
Committee at Janelia Farm Research Campus. Layer 2/3
pyramidal neurons in the barrel cortex were transfected via in
utero electroporation. The plasmids for electroporation contained
ChR2 fusion proteins (concentration, 2 mg/ml) and cytoplasmic
mCherry at 5:1 molar ratio.
Slice Preparation
Postnatalday15–23 mice wereused in theseexperiments. Animals
were deeply anesthetized with isofluorane. The brain was removed
andplacedinanice-coldcuttingsolutioncontaining110 mMcholine
chloride, 25 mM NaHCO3,2 5m MD - g l u c o s e ,1 1 . 6m Ms o d i u m
ascorbate, 7 mM MgCl2, 3.1 mM sodium pyruvate, 2.5 mM KCl,
1.25 mMNaH2PO4,and0. 5mMCa C l 2. Coronal slices of the barrel
cortex (300 mm thick) were cut with a vibrating slicer (Microm) and
incubated in oxygenated ACSF (127 mM NaCl, 25 mM NaHCO3,
25 mM D-glucose, 2.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2,a n d
1.25 mM NaH2PO4, aerated with 95% O2/5% CO2) for 45 min at
35uC before the recordings.
Figure 9. Interaction with Myosin VI promotes enrichment of
intracellular protein in axon. (A) CD8-MVIBD-tcs-GFP, which is
tagged on the extracellular N-terminus with a linker containing a
Thrombin cleavage site, expressed in a cortical neuron with Thrombin
in the medium and stained intracellularly with a rabbit anti-GFP
antibody. The relative expression level of intracellular CD8-MVIBD-tcs-
GFP in the axon is much higher than that of CD8-tcs-GFP (B), labeled
under conditions identical to those in (A), indicating that interaction
with Myosin VI promotes direct trafficking to the axon. (C) Comparison
of axonal staining of CD8-tcs-GFP with CD8-MVIBD-tcs-GFP in axons.
Top images in (C) correspond to areas surrounded by boxes in (A) and
(B). Scale bars are 10 mm. Insets show staining of endogenous Ankyrin
G. Arrows point to axon; arrowheads point to the axon initial segment.
doi:10.1371/journal.pbio.1001021.g009
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Recordings were performed at room temperature (22–24uC) in
the presence of glutamate receptor blockers (CPP, 5 mM; NBQX,
10 mM). Electrophysiology and stimulus conditions were largely as
described previously. The resting potentials of ChR2-MVIBD-
GFP-positive cells and ChR2-GFP-positive cells were indistin-
guishable (ChR2-MVIBD-positive, 26866 mV, n=6; ChR2,
26666 mV, n=6). The light source for photostimulation was
with a blue laser (473 nm; Crystal Laser), delivered through an air
immersion objective (46; 0.16 NA; UPlanApo, Olympus).
Photostimulation was with a beam diameter of 6–10 mm
(scattering in the tissue was not taken into account) on an 8616
grid with 50-mm spacing, except that three ChR2 venus cells were
recorded on an 8616 grid with 75-mm spacing. In this case, we
took only the same total area as a 50-mm spacing grid would cover.
Photostimuli consisted of light pulses with 1-ms durations and
powers in the range 5–1,000 mW at the specimen. Spikes were
recorded in whole-cell current clamp mode.
Inflection Point Analysis for ChR2-MVIDB and ChR2-
Expressing Neurons
Antidromic APs triggered in axons and triggered in soma and
dendrites could be distinguished by their waveforms. To determine
whether an AP evoked by photostimulation was dendritic or
axonal, we utilized the charging phase that is characteristic of
dendritic APs. For dendritic APs, this charging phase should reach
Figure 10. Myosin VI is necessary for endocytosis-independent localization of an axonal protein. In a cortical neuron in dissociated
culture, surface NgCAMY33A (A) localizes nonspecifically when expressed with GFP-dnMVI (B). (C) Merge of NgCAMY33A (red) and GFP-dnMVI
(green). In contrast, NgCAMY33A (D) localizes specifically to the axon when coexpressed with GFP (E). (F) Merge of NgCAMY33A (red) and GFP
(green). (G) The ADR of NgCAM coexpressed with GFP is approximately 5-fold greater than when it is coexpressed with GFP-dnMVI. *, p,0.0001
(Wilcoxon-Mann-Whitney test). Insets show staining of endogenous Ankyrin G. Arrows point to the axon; arrowheads point to the axon initial
segment. Scale bars are 10 mm.
doi:10.1371/journal.pbio.1001021.g010
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points. Otherwise, lack of charging phase would be categorized as
axonal APs. In order to determine whether there is a charging
phase and the position of the inflection point, we calculated the
first derivative of an AP trace. The AP is identified as a derivative
peak larger than 25 mV/ms; the charging phase is identified as a
derivative peak before the AP and larger than 0.5 mV/ms; and
the inflection point was found as the lowest derivative point
between the charging peak and the AP peak.
Supporting Information
Figure S1 Myosin VI is localized diffusely in both the
axonal and somatodendritic compartments. Staining of
endogenous Myosin VI (A) in a cortical neuron in dissociated
culture expressing GFP (B). Arrow points to the axon, arrowhead
points to the axon initial segment. Insets show staining of
endogenous Ankyrin G. Glial cell transfected with siRNA against
Myosin VI (arrows) (C) and GFP (D) shows dramatically reduced
staining of endogenous Myosin VI compared with an untrans-
fected cell. Untransfected cell stained for Myosin VI shows dark
labeling of a perinuclear structure characteristic of the Golgi
apparatus (arrowheads). Scale bars are 10 mm.
(PDF)
Figure S2 Structure and function of the MVIBD. CD8
fused with the MVIBD of DAB2 localizes somewhat to axons (A),
butisstillpresentindendritesina corticalneuroncoexpressingGFP
(B). Similarly, CD8 fused with the MVIBD of Optineurin localizes
somewhat to axons (C), but is still present in dendrites in a cortical
Figure 11. Interaction with Myosin VI promotes enrichment of ChR2 at the surface of axons of layer 2/3 pyramidal neurons. (A)
Image of an acute brain slice with a recoding electrode. Cortical layers (L1 to L6) and white matter (WM) are indicated on the left. Blue grid represents
8616 photostimulation patterns, with a spacing of 50 mm. (B) Schematic of waveforms triggered in soma and dendrites (red) and axons (blue). The
arrow marks the clear inflection point (see Materials and Methods). (C) Example maps from a ChR2-MVIBD-GFP-positive cell (left) and a ChR2-GFP-
positive cell (right). Black triangles mark soma locations. Blue traces indicate axonal excitation and red traces indicate somatic/dendritic excitation,
respectively, using inflection point criteria. (D) The ratio of the number of APs evoked in soma and dendrites to the number of APs evoked in axons
plotted against the laser power used for photostimulation. Blue circles represent the data points of the ChR2-MVIBD-GFP cells (n=6), and red circles
represent the data points of the ChR2-GFP cells (n=8). The upward shift of the eDAR distribution of ChR2-MVIBD-GFP relative to that of ChR2-GFP is
consistent with enrichment in axons of ChR2-MVIBD-GFP relative to ChR2-GFP.
doi:10.1371/journal.pbio.1001021.g011
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PLoS Biology | www.plosbiology.org 15 March 2011 | Volume 9 | Issue 3 | e1001021neuron coexpressing GFP (D). (E) Schematic of CD8-MVIBD
showing the Myosin VI binding sites of Optineurin and DAB2,
which are fused in series to the C-terminus of CD8. (F) In COS cells
cotransfected with GFP-MVIBD and HA-Myosin VI, immunopre-
cipitation with an anti-HA antibody coimmunoprecipitates both
HA-Myosin VI and GFP-MVIBD. In contrast, when cells are
transfected with GFP and HA-Myosin VI, immunoprecipitation
with an anti-HA antibody precipitates only HA-Myosin VI.
(PDF)
Figure S3 Expression of MVI siRNA dramatically
reduces expression of Myosin VI. Cortical neuron in culture
expressing NgCAM (A), GFP (B), and siRNA directed against
Myosin VI (C) exhibits diminished expression of Myosin VI.
Endogenous Myosin VI is expressed in cells in dissociated cortical
cultures at roughly 22% of the level that it is in cells expressing the
empty siRNA vector. The amount of fluorescence associated with
staining of Myosin VI in cells expressing MVI siRNA (FlMVI + MVI
siRNA) was 661 a.u., whereas for cells expressing the empty siRNA
vector (FlMVI + empty vector), it was 2665 a.u. (D). This difference is
significant (p , 0.0002, Wilcoxon-Mann-Whitney test). (E) When
HA-Myosin VI is coexpressed with siRNA in COS cells, a
Western blot stained with HA shows that there is virtually no HA-
Myosin VI present. In contrast, when HA-Myosin VI is
coexpressed with an empty siRNA vector or when MVI siRNA
is coexpressed with an HA-tagged variant of Myosin VI that is
impervious to siRNA (MVIr), there is HA staining indicating the
presence of Myosin VI. Staining for Beta Tubulin indicates that
equal amounts of protein were loaded in each case. *, p , 0.0001
(Wilcoxon-Mann-Whitney test). Arrow points to the axon. Scale
bars are 10 mm.
(PDF)
Figure S4 MVI siRNA blocks enrichment of CD8-
MVIBD at the axonal surface. CD8-MVIBD (A) is highly
enriched on the surface of the axon in a neuron cotransfected with
an empty siRNA vector and with GFP (B). (C) Merge of CD8-
MVIBD (red) and GFP (green) from (A) and (B). In contrast, when
CD8-MVIBD (D) is coexpressed with MVI siRNA and GFP (E), it
localizes in a nonspecific manner. (F) Merge of CD8-MVIBD (red)
and GFP (green) from (D) and (E). (G) ADR of CD8-MVIBD
coexpressed with siRNA empty vector is 4-fold greater than that of
CD8-MVIBD coexpressed with MVI siRNA. Scale bars are10
mm. *, p , 0.0001 (Wilcoxon-Mann-Whitney test).
(PDF)
Figure S5 Blocking Myosin VI function blocks localiza-
tion of axonal proteins. Surface staining of exogenous
NgCAM, exogenous CD8-Nav, and endogenous L1 (A, E, I)
showed that each localized specifically to the axon when
coexpressed with GFP (B, F, J). In contrast, surface NgCAM,
CD8-Nav, and L1 (C, G, K) localized nonspecifically when
coexpressed with GFP-dnMVI (D, H, L). Insets show staining of
endogenous Ankyrin G. Arrow points to the axon; arrowhead
points to the axon initial segment. Scale bars are 10 mm.
(PDF)
Figure S6 Ankyrin G ADR is uncorrelated with ADRs of
axonal proteins coexpressed with dnMVI. Scatter plots of
ADRs of CD8-Nav (A), NgCAM (B), and VAMP2 (C) versus ADR
of Ankyrin G for individual cortical neurons coexpressing GFP-
dnMVI. Correlation coefficients (R
2 , 0.03) indicate that the
ADRs of the axonal proteins and that of Ankyrin G are
uncorrelated.
(PDF)
Figure S7 Disruption of Myosin VI function or expres-
sion does not disrupt dendritic targeting. GFP-GluR1 (A)
localized to the dendrites when coexpressed with HA-dnMVI (B),
as did GFP-GluR1 (C) coexpressed with HA-mCherry (D), TfR-
HA (E) when coexpressed with GFP-dnMVI (F), surface GluR1
(G) when coexpressed with HA-dnMVI (H), and GFP-GluR1 (I)
when coexpressed with MVI siRNA and HA-mCherry (J). (K)
Comparison of ADRs indicates that blocking Myosin VI function
or its expression with a dominant negative variant of Myosin VI
does not significantly disrupt dendritic targeting. ns, p . 0.1.
Arrow points to the axon. Scale bars are 10 mm.
(PDF)
Figure S8 Neurons expressing MVI siRNA maintain
polarized morphology. (A) Cortical neuron expressing siRNA
against Myosin VI for 14 d. (B) High-power image of cell in (A)
showing that dendrites display a tapered morphology and the
presence of spines. (C) High-power image of cell in (A) and (B)
showing the axon with an untapered morphology and the absence
of spines. Note that arrowhead points to an autaptic connection.
Arrows point to axon. Scale bars are 10 mm.
(PDF)
Figure S9 Intracellular and surface CD8-MVIBD local-
ize differentially. Intracellular CD8-MVIBD localizes nonspe-
cifically (A), whereas surface CD8-MVIBD localizes specifically to
the axon (B). (C) Merge of surface (red) and intracellular (green)
CD8-MVIBD. Inset shows staining of endogenous Ankyrin G.
Arrow points to the axon; arrowhead points to the axon initial
segment. Scale bar is 10 mm. (D) The uADR (see Materials and
Methods) of surface CD8-MVIBD is significantly different from
that of the intracellular protein, which is higher than that of GFP.
*, p , 0.0001 (Wilcoxon-Mann-Whitney test).
(PDF)
Figure S10 Acid wash does not affect the localization of
endogenous proteins. (A) High-power image of internalized
CD8-MVIBD taken from cell in Figure 6A. (B) Cortical neuron
expressing GFP and exposed to pH 2 medium for 2 min in the
same manner as the neurons in Figure 6. (C and D) In the same
neuron as in (B) endogenous Ankyrin G and endogenous Nav1.2
showed appropriate staining in the axon initial segment, indicating
that the low pH treatment had not disrupted their localizations.
Scale bars are 10 mm.
(PDF)
Figure S11 Interaction with Myosin VI promotes direct
trafficking to the axon. (A) CD8-MVIBD-tcs-GFP, which is
tagged on the extracellular N-terminus with a linker containing a
Thrombin cleavage site, expressed in a cortical neuron with Thrombin
in the medium and stained intracellularly with a rabbit anti-GFP
antibody. The relative expression level of intracellular CD8-MVIBD-
tcs-GFP in the axon is much higher than that of CD8-tcs-GFP (B),
labeled under conditions identical to those in (A), indicating that
interaction with Myosin VI promotes direct trafficking to the axon. (C
and D) Surface staining with anti-GFP (using a monoclonal antibody)
shows that almost 100% of the surface protein was cleaved. (E)
Comparison of dendritic regions taken from 12 cells expressing CD8-
MVIBD and 13 cells expressing CD8, showing that expression in the
d e n d r i t e si sa tc o m p a r a b l el e v e l s .Note that each panel corresponds to
the same cells as the panel in the same position in Figure 9. (F) Cortical
neuron coexpressing GFP and SA-KDEL, an ER marker, show that
the ER is concentrated in the soma and dendrites and very sparse in
the axon. Note that SA-KDEL was stained using biotin-rhodamine.
Ankyrin staining is shown in the inset. Arrow points to axon;
Myosin VI and Localization of Axonal Proteins
PLoS Biology | www.plosbiology.org 16 March 2011 | Volume 9 | Issue 3 | e1001021arrowhead points to axon initial segment. (G) Cortical neurons were
exposed to biotinylated Thrombin in the bath under conditions
identical to those for the experiments in (A–E) and in Figure 9.
Subsequently, the cell was fixed, permeabilized, and stained using SA-
rhodamine to determine whether the Thrombin had been internalized.
The lack of staining in the right panel corresponding to GFP staining in
the left panel indicates that very little if any Thrombin was internalized.
(PDF)
Figure S12 ChR2-MVIBD expression in slices of cortex
following in utero electroporation. Brain section (50 mm
thick) from a 4-wk-old mouse electroporated at embryonic day 16
with ChR2-MVIBD-GFP and mCherry, which labeled layer 2/3
(L2/3) neurons. These neurons had exuberant axons in layer 2/3
and layer 5, consistent with prominent ChR2-MVIBD-GFP
staining in layer 2/3 and layer 5 positions, while mCherry
staining was strongest in layer 2/3 in somata. Also note that both
intracellular and surface protein was labeled, so the expression
pattern shown is not necessarily the same as that of surface protein.
Scale bar is 100 mm.
(PDF)
Figure S13 Histograms of membrane potentials at
inflection points. Histograms for (A) ChR2-MVIBD-GFP cells
(n=6) and (B) ChR2-GFP cells (n=8). For each neuron,
responses from all laser power stimulations are plotted. Red
dashed lines in all cells indicate the threshold (15 mV) for
determining axonal versus somatic/dendritic responses. In ChR2-
GFP cells there is a small bump in higher membrane potentials,
indicating the dendritic component, while this bump almost
disappeared in ChR2-MVIBD-GFP cells. In general, there is a
trend towards lower membrane potentials in ChR2-MVIBD-GFP
cells than in the control ChR2-GFP cells.
(PDF)
Figure S14 Myosin VI-dependent mechanisms for local-
ization of axonal proteins. Proteins are loaded into vesicles on
the surface of the Golgi apparatus and from there are transported
either to the axon or to the dendrites by kinesin motors (purple) on
microtubules (blue). After the protein sent to the dendrites is
deposited on the dendritic surface, it is endocytosed through the
actions of Myosin VI (orange, Box B). Proteins loaded into vesicles
that proceed to the axon are carried by kinesin motors along
microtubules. It is possible that Myosin VI might also guide these
vesicles towards the axon by moving along actin filaments (pink)
with their plus ends oriented towards the cell body (Box A). In this
paper we provide direct evidence that dendrite-specific endocytosis
is involved in localization of axonal proteins. Other experiments
suggest that a direct mechanism such as the one shown in Box A
might also contribute to axonal trafficking, although additional
experiments will be required to fully define this mechanism. Note
that, for simplicity, only a single microtubule was drawn in the
dendrite although there are, in fact, microtubules pointing in both
directions.
(PDF)
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